+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English

Global Recombinant Human Serum Albumin Market is Projected to Reach 1.3 Tonnes by 2024

Author: QYResearch | Publish date: 2018-05-31 | Views: 42
The Recombinant Human Serum Albumin industry was 0.77 tonnes in 2017 and is projected to reach 1.3 tonnes by 2025, at a CAGR (Compounded Annual Growth Rate) of 6.7% between 2017 and 2024. The market is driven by various end-user industries, such as Cell Culture Media, Medical Supplements, etc.


The industry is concentration, the key brand includes Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia and so on. Among them, Albumedix, Merck are the leaders.


The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.


Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E. coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.

 

Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.


The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.


The Global Recombinant Human Serum Albumin Market Research Report 2017 report released by QYResearch provides a basic overview of the Recombinant Human Serum Albumin industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.


The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Recombinant Human Serum Albumin industry development trends and marketing channels were analysed. Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.


CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>